A Review Of Paniculoside I
All enrolled people who obtained at least one particular dose of zosuquidar or placebo throughout induction have been monitored for your incidence of adverse situations (439 patients, 219 on zosuquidar and 210 on placebo). The most common adverse functions ended up related to the duration of extended and significant myelosuppression as is anticipat